|
New JRC-IHCP call on nanotechnology safety assessment (Nanowerk, 5/25/09) |
|
|
|
|
June 06, 2009 |
(Nanowerk News) By this Call for Expressions of Interest (CEI) the Joint Research Centre, Institute for Health and Consumer Protection, Management Support Unit, will made up the list of service providers which will be used for the conclusion of public contracts on certain services to be provided to the Institute. The object of this call for expression of interest is the provision of services in the field of nanotechnology — safety assessment of products and substances.
Notice has been given by the Institute for Health and Consumer Protection, at the Joint Research Centre of the launch of a call for expression of interest (CEI) for “Nanotechnology — safety assessment of products and substances”.
All institutes, organisations or companies wishing to be included on the list of service providers for the Institute for Health and Consumer Protection are invited to submit an application in accordance with the rules set out in this notice for the purpose specified. There is no special legal form is required from applicants.
The awarding authority will draw up a list of candidates whose applications meet the criteria set out in the call, which will be subdivided into sub-lists, each of which will correspond to one of the following fields:
· IT platform for nanomaterials NAPIRAhub: substance-related management of information, database management, adaptation of the data model, adaptation of the data structure, tool adaptation, such as query tools, installation and communication support, training for users.
· Nanotechnology: substance identification and definition.
· Nanotechnology: information requirements for nanomaterials for safety assessment.
· Test methods and testing strategies for manufactured nanomaterials: environmental toxicity and environmental fate.
· Test methods and testing strategies for manufactured nanomaterials: human health hazards.
· Risk assessment and safety assessment methodology for nanomaterials, exposure scenarios, risk management measures, dose descriptors.
· Reference nanomaterials, reference substances, repository of substances, distribution.
· Nanomaterial characterisation, homogeneity and stability: physico-chemical and biophysical measurements.
http://www.nanowerk.com/news/newsid=10796.php
|
